Live Breaking News & Updates on எரிக் ஐசென்மேன்

Stay updated with breaking news from எரிக் ஐசென்மேன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Finding a way to stop chemotherapy from damaging the heart


Finding a way to stop chemotherapy from damaging the heart
There could be an intervention on the horizon to help prevent heart damage caused by the common chemotherapy drug doxorubicin, new research suggests.
Scientists found that this chemo drug, used to treat many types of solid tumors and blood cancers, is able to enter heart cells by hitchhiking on a specific type of protein that functions as a transporter to move a drug from the blood into heart cells.
Kevin Huang
By introducing another anti-cancer drug in advance of the chemo, the researchers were able to block the transporter protein, effectively stopping the delivery of doxorubicin to those cardiac cells. This added drug, nilotinib, has been previously found to inhibit activation of other, related transport proteins. ....

United States , Ohio State University , Ralf Bundschuh , Qiang Fu , Kevin Huang , Megan Zavorka Thomas , Eric Eisenmann , Pearlly Yan , Alexander Pan , Duncan Digiacomo , Robert Bosch Stiftung , Ingrid Bonilla , Sharyn Baker , Sakima Smith , Daniel Addison , Alice Gibson , Alex Sparreboom , Vincenzo Coppola , Muhammad Erfan Uddin , Moray Campbell , Cynthia Carnes , Maryam Lustberg , Sherry Xia , Yang Li , German Research Foundation , Proceedings Of The National Academy Sciences ,

Finding a way to stop chemotherapy from damaging the heart


Finding a way to stop chemotherapy from damaging the heart
Study suggests drug intervention may prevent doxorubicin-induced cardiac injury
There could be an intervention on the horizon to help prevent heart damage caused by the common chemotherapy drug doxorubicin, new research suggests.
Scientists found that this chemo drug, used to treat many types of solid tumors and blood cancers, is able to enter heart cells by hitchhiking on a specific type of protein that functions as a transporter to move a drug from the blood into heart cells.
By introducing another anti-cancer drug in advance of the chemo, the researchers were able to block the transporter protein, effectively stopping the delivery of doxorubicin to those cardiac cells. This added drug, nilotinib, has been previously found to inhibit activation of other, related transport proteins. ....

United States , Ohio State University , Ralf Bundschuh , Qiang Fu , Kevin Huang , Megan Zavorka Thomas , Eric Eisenmann , Pearlly Yan , Alexander Pan , Duncan Digiacomo , Robert Bosch Stiftung , Ingrid Bonilla , Sharyn Baker , Sakima Smith , Daniel Addison , Alice Gibson , Alex Sparreboom , Vincenzo Coppola , Muhammad Erfan Uddin , Moray Campbell , Cynthia Carnes , Maryam Lustberg , Sherry Xia , Yang Li , German Research Foundation , Proceedings Of The National Academy Sciences ,